Justia Mergers & Acquisitions Opinion Summaries
In re El Paso Pipeline Partners, L.P. Derivative Litig.
In 2010, El Paso Corporation (“El Paso Parent”) sold member interests in three limited liability companies to El Paso Pipeline Partners, LP (“El Paso MLP”). At the time of the sale, El Paso Parent controlled El Paso MLP through its ownership of El Paso Pipeline GP Company, LLC, the sole general partner of El Paso MLP (“El Paso GP”). In 2015, the Court of Chancery issued a post-trial decision concluding that El Paso GP breached the limited partnership agreement governing El Paso MLP by causing El Paso MLP to buy the member interests (the “Fall Dropdown”). In 2012, Plaintiff brought this action challenging the Fall Droptown. While the litigation was pending, Kinder Morgan, Inc., acquired El Paso Parent and therefore indirectly owned and controlled El Paso GP. After trial, Kinder Morgan, El Paso Parent, El Paso MLP, and El Paso GP consummated a merger that ended El Paso MLP’s separate existence as a publicly traded entity. El Paso GP moved to dismiss this litigation, arguing that because Plaintiff styled his claim as derivative the closing of the merger meant that this case must be dismissed. The Court of Chancery denied El Paso GP’s motion to dismiss, holding that the merger did not extinguish Plaintiff’s standing to pursue the claim, and therefore, this Court can implement the liability award. View "In re El Paso Pipeline Partners, L.P. Derivative Litig." on Justia Law
Santa Clarita Org. v. Abercrombie
SCOPE filed suit claiming that the acquisition of the Valenica Water Company by the Castaic Lake Water Agency was void under Government Code section 1090 and the Political Reform Act (PRA), Gov. Code 81000 et seq., because one of the Agency's ten directors - Keith Abercrombie- was Valencia's general manager at the time the acquisition was be negotiated. The trial court rejected SCOPE's conflict of interest claims. The court affirmed the trial court's decision, concluding that the express exception to section 1090 in the Agency’s enabling legislation applies to a contract to acquire a water company; the express exception to section 1090 also implicitly repeals (and thereby amends) the PRA’s applicability to such an acquisition; and the Legislature complied with the special requirements set forth in section 81012 for amending the PRA, which was originally enacted by voter initiative. View "Santa Clarita Org. v. Abercrombie" on Justia Law
Pharmaceutical Research v. FTC
The Hart-Scott-Rodino Antitrust Improvements Act of 1976 (Act), 15 U.S.C. 18a, added section 7A to the Clayton Antitrust Act of 1914, 15 U.S.C. 12 et seq., to establish notification and waiting requirements for large acquisitions and mergers. The principal purpose of the Act is to facilitate Government identification of mergers and acquisitions likely to violate federal antitrust laws before the proposed deals are consummated. In 2013, the FTC modified its reportable asset acquisition regulations to clarify that, even if patent holders retain limited manufacturing rights or co-rights, transfers of patent rights within the pharmaceutical industry constitute reportable asset acquisitions if all commercially significant rights are transferred. PhRMA filed suit challenging the FTC's Rule and the district court granted summary judgment in favor of the FTC. The court concluded that the Rule does not violate the plain terms of the Act; the court owes deference to the FTC because the contested rule embodies a permissible construction of the Act; and the Commission's action also survives review under the arbitrary and capricious standard. Because the FTC's action is supported by reasoned decisionmaking and PhRMA's claims are without merit, the court affirmed the judgment of the district court. View "Pharmaceutical Research v. FTC" on Justia Law
In re Jefferies Group, Inc. Shareholders Litig.
This action arose out of the stock-for-stock merger of Jefferies Group, Inc. and Leucadia National Corporation. After the transaction was announced, the first of seven actions challenging the proposed transactions as filed in New York state court. The case subsequently proceeded in Delaware. Before trial began, the parties reached an agreement-in-principle to settle the case. The settlement, which was formally approved by the Court of Chancery, resulted in a payment of $70 million to the Class. Delaware Counsel sought an award of attorneys’ fees and expenses, and New York Plaintiffs filed a motion for a share of the fee award. The Court of Chancery (1) held that Delaware Counsel was entitled to a fee award of $21.5 million, which equated to 23.5 percent of the gross value of the settlement; and (2) denied the New York Plaintiffs’ motion for a share of the fee award in this action, holding that the New York Plaintiffs failed to substantiate their contribution to the results achieved in the Delaware action. View "In re Jefferies Group, Inc. Shareholders Litig." on Justia Law
Posted in:
Mergers & Acquisitions
AngioDynamics, Inc. v. Biolitec AG
Plaintiff obtained a $23 million judgment in New York against a New Jersey corporation ("Corporation") with its principal place of business in Massachusetts. Plaintiff sought to secure payment on that judgment by bringing suit in the District of Massachusetts against the Corporation’s president and its corporate parents, alleging that Defendants had looted BI of more than $18 million in assets in order to render it judgment-proof. Plaintiff later learned that one of BI’s corporate parents planned to merge with an Austrian subsidiary, which would place the company’s assets out of Plaintiff’s reach. The district court issued a temporary restraining order, later converted into a preliminary injunction, barring the merger. Defendant unsuccessfully moved to vacate the injunction and then appealed. While the appeal was pending, Defendants effected the merger. The district court issued civil contempt sanctions on Defendant for violating the court’s preliminary injunction order. The First Circuit affirmed, holding that the district court (1) did not exceed the bounds of its authority when it imposed the civil contempt sanctions; and (2) did not err when it declined to vacate the underlying preliminary injunction. View "AngioDynamics, Inc. v. Biolitec AG" on Justia Law
Posted in:
Business Law, Mergers & Acquisitions
St. Alphonsus Med. Ctr. v. St. Luke’s Health Sys.
The FTC and the State filed suit alleging that the 2012 merger of two health care providers in Nampa, Idaho violated section 7 of the Clayton Act, 15 U.S.C. 18, and state law. The district court found that the merger violated section 7 and ordered divestiture. The court affirmed the judgment, concluding that the district court's determination that Nampa was the relevant geographic market was supported by the record; the district court did not clearly err in holding that plaintiffs established a prima facie case that the merger will probably lead to anticompetitive effects in the market; and defendant failed to rebut the prima facie case by demonstrating that efficiencies resulting from the merger would have a positive effect on competition. Therefore, in this case, the district court did not abuse its discretion in choosing divestiture. View "St. Alphonsus Med. Ctr. v. St. Luke's Health Sys." on Justia Law
Posted in:
Antitrust & Trade Regulation, Mergers & Acquisitions
In re Appraisal of Dole Food Co., Inc.
After David H. Murdock, the CEO and controlling stockholder of Dole Food Company, Inc., acquired all the shares of Dole common stock that he did not already own, Petitioners pursued their statutory right to an appraisal of their shares of Dole common stock. During discovery, Dole sought information about any valuations of Dole common stock that Petitioners prepared, reviewed, or considered when buying to selling Dole common stock or when seeking appraisal. Petitioners objected to the document requests. Dole subsequently served notices of deposition for each Petitioner pursuant to Court of Chancery Rule 30(b)(6) and identified the valuations as a topic of questioning. During the depositions, Petitioners’ counsel instructed the Rule 30(b)(6) witnesses not to testify about the valuations on the basis of relevance. Dole moved to compel production of the valuation-related information and for supplemental Rule 30(b)(6) depositions. The Court of Chancery granted the motion, holding that, under the circumstances, Petitioners’ failure to provide the discovery was not substantially justified. View "In re Appraisal of Dole Food Co., Inc." on Justia Law
Posted in:
Business Law, Mergers & Acquisitions
Cigna Health & Life Ins. Co. v. Audax Health Solutions, Inc.
Plaintiff, Cigna Health and Life Insurance Co., challenged Optum Services, Inc’s acquisition by merger, via Audax Holdings, Inc., of Audax Health Solutions, Inc. Plaintiff moved for judgment on the pleadings, arguing that certain provisions of the merger agreement were contrary to the Delaware General Corporation Law. Those provisions related to a release of claims, an indemnification requirement, and the appointment of a stockholder representative. The Court of Chancery granted the motion in part and denied it in part, holding (1) the release of claims lacks any force because the buyer attempted to impose that obligation in a contract lacking consideration; (2) the indemnification provision violates 8 Del. Cas. 251; and (3) Plaintiff failed to brief the stockholder representative issue sufficiently to support its request for judgment as a matter of law. View "Cigna Health & Life Ins. Co. v. Audax Health Solutions, Inc." on Justia Law
Posted in:
Mergers & Acquisitions
Baker v. Goldman, Sachs & Co.
Dragon Systems, Inc. (Dragon), a voice recognition software company that faced a deteriorating financial situation, hired Goldman Sachs (Goldman) to provide financial advice and assistance in connection with a possible merger. In 2000, Lernout & Hauspie Speech Products N.V. (Lernout & Hauspie) acquired Dragon. When it was discovered that Lernout & Hauspie had fraudulently overstated its earnings, the merged company filed for bankruptcy, and the Dragon name and technology were sold from the estate. Plaintiffs, two groups of Dragon shareholders, filed suit against Goldman, alleging negligent and intentional misrepresentation, negligence, gross negligence, breach of fiduciary duty, and violations of Mass. Gen. Laws ch. 93A. A jury found in favor of Goldman on Plaintiffs’ common law claims, and district court found that Goldman had not violated chapter 93A. The First Circuit affirmed, holding (1) the district court correctly articulated the legal standard applicable to Plaintiffs’ chapter 93A claims and correctly applied that standard to its factual findings; and (2) Plaintiffs’ arguments that they were entitled to a new trial on their common law claims because of evidentiary errors and erroneous jury instructions were without merit. View "Baker v. Goldman, Sachs & Co." on Justia Law
In re TPC Group Inc. S’holders Litig.
After TPC Group Inc. announced its acquisition by First Reserve Corporation, SK Capital Partners, and their affiliates (collectively, the PE Group), Plaintiffs, shareholders of TPC, brought a class action against TPC, the TPC’s board of directors, and the PE Group (collectively, Defendants). Plaintiffs’ claims were later mooted, and the Court of Chancery awarded attorneys’ fees for the disclosures resulting from Plaintiffs’ efforts. At issue before the Court was whether Plaintiffs were entitled to attorneys’ fees for the increase in the merger price achieved between the commencement of this litigation and the acquisition’s closing under an amended merger agreement. The Court of Chancery denied Plaintiffs’ application for an award of attorneys’ fees and expenses for the increase in the merger price, concluding that Plaintiffs did not cause the price increase in any way. View "In re TPC Group Inc. S’holders Litig." on Justia Law
Posted in:
Mergers & Acquisitions